Pascal Biosciences Inc's total assets for Q3 2024 were C$2.17M, a decrease of -1.42% from the previous quarter. TSE:NEVI total liabilities were C$887.93K for the fiscal quarter, a -5.13% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.